Literature DB >> 2276016

Epidermal growth factor receptor expression in colorectal cancer.

R J Steele1, P Kelly, B Ellul, O Eremin.   

Abstract

Epidermal growth factor (EGF) receptor expression was estimated in 50 invasive human colorectal cancers using immunohistochemistry and the degree of expression was quantified from integrated optical density measurements on the stained sections. All tumours stained positively, but Dukes' C tumours exhibited significantly higher levels of receptor than either Dukes' A or B tumours. In addition, histologically high grade cancers expressed receptors more strongly than those of low grade. It is concluded that a high EGF receptor concentration is associated with poor prognostic factors in colorectal malignancy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276016     DOI: 10.1002/bjs.1800771211

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  15 in total

1.  Raf-1 kinase, epidermal growth factor receptors, and mutant Ras proteins in colonic carcinomas.

Authors:  S Eggstein; G Manthey; T Hirsch; F Baas; B U Specht; E H Farthmann
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 2.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 3.  KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

Authors:  J H J M van Krieken; A Jung; T Kirchner; F Carneiro; R Seruca; F T Bosman; P Quirke; J F Fléjou; T Plato Hansen; G de Hertogh; P Jares; C Langner; G Hoefler; M Ligtenberg; D Tiniakos; S Tejpar; G Bevilacqua; A Ensari
Journal:  Virchows Arch       Date:  2008-09-18       Impact factor: 4.064

4.  Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx.

Authors:  Satoshi Fujii; Hideoki Uryu; Ken Akashi; Kensuke Suzuki; Manabu Yamazaki; Makoto Tahara; Ryuichi Hayashi; Atsushi Ochiai
Journal:  Int J Clin Oncol       Date:  2012-03-24       Impact factor: 3.402

Review 5.  A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.

Authors:  Vanessa Deschoolmeester; Marc Baay; Pol Specenier; Filip Lardon; Jan B Vermorken
Journal:  Oncologist       Date:  2010-06-28

Review 6.  EGFR and colon cancer: a clinical view.

Authors:  J de Castro-Carpeño; C Belda-Iniesta; E Casado Sáenz; E Hernández Agudo; J Feliu Batlle; M González Barón
Journal:  Clin Transl Oncol       Date:  2008-01       Impact factor: 3.405

Review 7.  Mechanisms of resistance to EGFR targeted therapies.

Authors:  Gorjan Hrustanovic; Bianca J Lee; Trever G Bivona
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

8.  ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery.

Authors:  Glauco Baiocchi; Ademar Lopes; Renata A Coudry; Benedito M Rossi; Fernando A Soares; Samuel Aguiar; Gustavo C Guimarães; Fabio O Ferreira; Wilson T Nakagawa
Journal:  Int J Colorectal Dis       Date:  2009-04-24       Impact factor: 2.571

9.  HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer.

Authors:  Toru Kawamoto; Savitri Krishnamurthy; Emily Tarco; Smita Trivedi; Ignacio I Wistuba; Donghui Li; Ivan Roa; Juan C Roa; Melanie B Thomas
Journal:  Gastrointest Cancer Res       Date:  2007-11

Review 10.  The epidermal growth factor receptor as a target for gastrointestinal cancer therapy.

Authors:  Karen L Tedesco; A Craig Lockhart; Jordan D Berlin
Journal:  Curr Treat Options Oncol       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.